We report here a case of hepatocellular carcinoma (HCC) with multiple lung metastases, which were disappeared by treatment of OK-432. The patient was a 65-year-old man and was diagnosed in 1986 with a small (17 x 11 mm) HCC in the anterior-superior segment of the liver. A part of the right hepatic lobe including the tumor was surgically removed, and transarterial injections of adriamycin (10 mg/week) and subcutaneous injections of OK-432 (10 KE/week) were given. Two and a half years later, recurrence of HCC in the liver and its invasion to vena cava inferior (IVC) were found. OK-432 administration was then stopped and percutaneous ethanol injection therapy (PEIT) was performed 10 times. Six months later, the PEIT was effective and the liver...
Hepatocellular carcinoma is rare, but increasing in prevalence in the United States. Recent studies ...
Over the past decade, standard first-line systemic treatment of advanced hepatocellular carcinoma (H...
We treated a patient with non-small cell lung cancer (NSCLC) and an isolated hepatic metastasis. He ...
We report here a case of hepatocellular carcinoma (HCC) with multiple lung metastases, which were di...
Introduction: Advanced or metastatic hepatocellular carcinoma (HCC) can be lethal because of the lim...
Hepatocellular carcinoma (HCC) is the third leading cause of death by cancer worldwide. The prognosi...
Cardiac metastasis originating from hepatocellular carcinoma (HCC) is a rare condition with a poor p...
Hepatocellular cancer (HCC) is increasing dramatically in incidence in Europe and the United States ...
with pulmonary metastases treated with repeated hepatic arterial infusion chemotherapy (HAIC) com-pr...
The clinical efficacy of local ablative treatment for oligometastasis is widely accepted in most can...
Background: Hepatocellular carcinoma (HCC) is a common malignancy worldwide and treatment options ar...
Introduction : Despite various treatment trials for unresectable pancreatic carcinoma with liver met...
Hepatoid adenocarcinoma of the lung is a rare subtype of lung cancer. We report a case of a metastat...
We describe the case of a 75 years old patient with a history of hepatocellular carcinoma, with acut...
© 2014 Royal Australasian College of Surgeons. Background: This study investigates whether there has...
Hepatocellular carcinoma is rare, but increasing in prevalence in the United States. Recent studies ...
Over the past decade, standard first-line systemic treatment of advanced hepatocellular carcinoma (H...
We treated a patient with non-small cell lung cancer (NSCLC) and an isolated hepatic metastasis. He ...
We report here a case of hepatocellular carcinoma (HCC) with multiple lung metastases, which were di...
Introduction: Advanced or metastatic hepatocellular carcinoma (HCC) can be lethal because of the lim...
Hepatocellular carcinoma (HCC) is the third leading cause of death by cancer worldwide. The prognosi...
Cardiac metastasis originating from hepatocellular carcinoma (HCC) is a rare condition with a poor p...
Hepatocellular cancer (HCC) is increasing dramatically in incidence in Europe and the United States ...
with pulmonary metastases treated with repeated hepatic arterial infusion chemotherapy (HAIC) com-pr...
The clinical efficacy of local ablative treatment for oligometastasis is widely accepted in most can...
Background: Hepatocellular carcinoma (HCC) is a common malignancy worldwide and treatment options ar...
Introduction : Despite various treatment trials for unresectable pancreatic carcinoma with liver met...
Hepatoid adenocarcinoma of the lung is a rare subtype of lung cancer. We report a case of a metastat...
We describe the case of a 75 years old patient with a history of hepatocellular carcinoma, with acut...
© 2014 Royal Australasian College of Surgeons. Background: This study investigates whether there has...
Hepatocellular carcinoma is rare, but increasing in prevalence in the United States. Recent studies ...
Over the past decade, standard first-line systemic treatment of advanced hepatocellular carcinoma (H...
We treated a patient with non-small cell lung cancer (NSCLC) and an isolated hepatic metastasis. He ...